[HTML][HTML] A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD

M Guo, Z Sun, QY Sun, Q Han, CL Yu, DH Wang… - Biology of Blood and …, 2009 - Elsevier
Severe graft-versus-host disease (GVHD) and graft rejection still remain major complications
of haploidentical nonmyeloablative (NMA) stem cell transplantation. Recent studies have …

A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.

M Guo, Z Sun, QY Sun, Q Han, CL Yu… - Biology of Blood and …, 2009 - europepmc.org
Severe graft-versus-host disease (GVHD) and graft rejection still remain major complications
of haploidentical nonmyeloablative (NMA) stem cell transplantation. Recent studies have …

[PDF][PDF] A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for high-Risk Acute Leukemia: Successful Engraftment and Mild GVHD

M Guo, Z Sun, QY Sun, Q Han, CL Yu… - Biol Blood Marrow …, 2009 - core.ac.uk
Haploidentical hematopoietic stem cell transplantation (HSCT) can provide a curable
opportunity for patients with leukemia who are suitable for HSCT, but lack an HLA matched …

[PDF][PDF] A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for high-Risk Acute Leukemia: Successful Engraftment and Mild GVHD

M Guo, Z Sun, QY Sun, Q Han, CL Yu… - Biol Blood Marrow …, 2009 - scholar.archive.org
Haploidentical hematopoietic stem cell transplantation (HSCT) can provide a curable
opportunity for patients with leukemia who are suitable for HSCT, but lack an HLA matched …

[PDF][PDF] A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for high-Risk Acute Leukemia: Successful Engraftment and Mild GVHD

M Guo, Z Sun, QY Sun, Q Han, CL Yu… - Biol Blood Marrow …, 2009 - cyberleninka.org
Haploidentical hematopoietic stem cell transplantation (HSCT) can provide a curable
opportunity for patients with leukemia who are suitable for HSCT, but lack an HLA matched …

[引用][C] A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for High-Risk Acute Leukemia: Successful Engraftment and Mild GVHD

M Guo, Z Sun, QY Sun, Q Han, CL Yu… - Biology of Blood and …, 2009 - cir.nii.ac.jp
A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for
High-Risk Acute Leukemia: Successful Engraftment and Mild GVHD | CiNii Research CiNii …

A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for High-Risk Acute Leukemia: Successful Engraftment and Mild GVHD

M Guo, Z Sun, QY Sun, Q Han, CL Yu… - Biology of Blood and …, 2009 - infona.pl
Severe graft-versus-host disease (GVHD) and graft rejection still remain major complications
of haploidentical nonmyeloablative (NMA) stem cell transplantation. Recent studies have …

[HTML][HTML] A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for High-Risk Acute Leukemia: Successful Engraftment and Mild GVHD

M Guo, Z Sun, QY Sun, Q Han, CL Yu… - Biology of Blood and …, 2009 - astctjournal.org
Severe graft-versus-host disease (GVHD) and graft rejection still remain major complications
of haploidentical nonmyeloablative (NMA) stem cell transplantation. Recent studies have …

[HTML][HTML] A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for High-Risk Acute Leukemia: Successful Engraftment and Mild GVHD

M Guo, Z Sun, QY Sun, Q Han, CL Yu… - Biology of Blood and …, 2009 - tctjournal.org
Severe graft-versus-host disease (GVHD) and graft rejection still remain major complications
of haploidentical nonmyeloablative (NMA) stem cell transplantation. Recent studies have …

A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD

M Guo, Z Sun, QY Sun, Q Han… - Biology of blood …, 2009 - pubmed.ncbi.nlm.nih.gov
Severe graft-versus-host disease (GVHD) and graft rejection still remain major complications
of haploidentical nonmyeloablative (NMA) stem cell transplantation. Recent studies have …